GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Accounts Payable & Accrued Expense

4d pharma (4d pharma) Accounts Payable & Accrued Expense : $2.05 Mil (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Accounts Payable & Accrued Expense?

4d pharma's quarterly accounts payable & accrued expense increased from Dec. 2020 ($4.77 Mil) to Jun. 2021 ($9.76 Mil) but then declined from Jun. 2021 ($9.76 Mil) to Dec. 2021 ($2.05 Mil).

4d pharma's annual accounts payable & accrued expense increased from Dec. 2019 ($1.97 Mil) to Dec. 2020 ($4.77 Mil) but then declined from Dec. 2020 ($4.77 Mil) to Dec. 2021 ($2.05 Mil).


4d pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for 4d pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Accounts Payable & Accrued Expense Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 3.70 2.83 1.97 4.77 2.05

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 8.04 4.77 9.76 2.05

4d pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


4d pharma (4d pharma) Business Description

Industry
Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.